Oslo, Norway, 7 August 2026 - Photocure ASA (the "Company") (OSE: PHO) has
granted share options to the members of the board of directors.
The Company has issued the annual share options to the members of the board of
directors in accordance with the resolution made under section 5 of the annual
general meeting held 26 June 2026. Chairperson, Dylan Huss Hallerberg, was
issued 19,221 share options, and the other members of the board, Neal Shore and
Ghizlane Tagmouti were issued 10,377 options each. The strike price was set at a
10% premium to the weighted average closing price in the 30 business days
following the annual general meeting on 26 June 2026, which corresponds to a
strike price of NOK 58.90 per share.
Primary insider notifications pursuant to the Market Abuse Regulation Article 19
are attached.
For further information, please contact:
Priyam Shah
Vice President Investor Relations
Tel: +17176815072
Email: priyam.shah@photocure.com
About Photocure ASA
Photocure is a commercial diagnostic company with global reach, committed to
driving progress in uro-oncology precision diagnostics, delivering meaningful
advances for patients with urological cancers. Our unique core technology has
led to better health outcomes for patients worldwide. The company aims to
provide an array of transformative solutions that help physicians with timely
diagnostic information, to inform more personalized decisions on how best to
manage each individual patient. Photocure is headquartered in Oslo, Norway and
listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit
www.photocure.com/news
This information is subject to the disclosure requirements pursuant to Article
19 of the Market Abuse Regulation and Section 5-12 of the Norwegian Securities
Trading Act.
ction 5-12 of the Norwegian Securities\
Trading Act.\